Human lactoferrin interacts with soluble CD14 and inhibits expression of endothelial adhesion molecules, E-selectin and ICAM-1, induced by the CD14-lipopolysaccharide complex

Infection and Immunity

Volumn 68, Issue 12, 2000, Pages 6519-6525

  Baveye, S ^a   Elass, E ^a   Fernig, D G ^b   Blanquart, C ^a   Mazurier, J ^a   Legrand, D ^a  

^a UNIVERSITÉ DES SCIENCES ET TECHNOLOGIES DE LILLE   (France)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; LACTOFERRIN; LIPOPOLYSACCHARIDE;

AFFINITY CHROMATOGRAPHY; ARTICLE; BINDING AFFINITY; BINDING KINETICS; CELL CULTURE; ENDOTHELIUM CELL; ESCHERICHIA COLI; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; SALMONELLA ENTERICA; SEPTIC SHOCK; UMBILICAL VEIN;

AMINO ACID SEQUENCE; ANTIGENS, CD14; CELLS, CULTURED; E-SELECTIN; ENDOTHELIUM, VASCULAR; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; LACTOFERRIN; LIPOPOLYSACCHARIDES; MOLECULAR SEQUENCE DATA;

EID: 0034440799     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.12.6519-6525.2000     Document Type: Article

References (52)

1. Anderson, B. F., H. M. Baker, G. E. Norris, D. W. Rice, and E. N. Baker. 1989. Structure of human lactoferrin: crystallographic structure analysis and refinement at 2.8 A resolution. J. Mol. Biol. 209:711-734.
2. Appelmelk, B. J., Y. Q. An, M. Geerts, B. G. Thijs, H. A. de Boer, D. M. MacLaren, J. de Graaff, and J. H. Nuijens. 1994. Lactoferrin is a lipid A-binding protein. Infect. Immun. 62:2628-2632.
3. Arditi, M., J. Zhou, R. Dorio, G. W. Rong, S. M. Goyert, and K. S. Kim. 1993. Endotoxin-mediated endothelial cell injury and activation: role of soluble CD14. Infect. Immun. 61:3149-3156.
4. Baveye, S., E. Elass, J. Mazurier, G. Spik, and D. Legrand. 1999. Lactoferrin: a multifunctional glycoprotein involved in the modulation of the inflammatory process. Clin. Chem. Lab. Med. 37:281-286.
5. Bazil, V., M. Baudys, I. Hilgert, I. Stefanova, M. G. Low, J. Zbrozek, and V. Horejsi. 1989. Structural relationship between the soluble and membrane-bound forms of human monocyte surface glycoprotein CD14. Mol. Immunol. 26:657-662.
6. Bennett, R. M., and C. Mohla. 1976. A solid-phase radioimmunoassay for the measurement of lactoferrin in human plasma: variations with age, sex, and disease. J. Lab. Clin. Med. 88:156-166.
7. Bevilacqua, M. P., J. S. Pober, D. L. Mendrick, R. S. Cotran, and M. A. Gimbrone, Jr. 1987. Identification of an inducible endothelial-leukocyte adhesion molecule. Proc. Natl. Acad. Sci. USA 84:9238-9242.
8. Bone, R. C. 1991. The pathogenesis of sepsis. Ann. Intern. Med. 115:457-469.
9. Cavaillon, J. M., C. Marie, A. Ledur, I. Godard, D. Poulain, C. Fitting, and N. Haeffner-Cavaillon. 1996. CD14/LPS receptor exhibits lectin-like properties. J. Endotoxin Res. 3:471-480.
10. Crouch, S. P., K. J. Slater, and J. Fletcher. 1992. Regulation of cytokine release from mononuclear cells by the iron-binding protein lactoferrin. Blood 80:235-240.
11. Dentener, M. A., V. Bazil, E. J. Von Asmuth, M. Ceska, and W. A. Buurman. 1993. Involvement of CD14 in lipopolysaccharide-induced tumor necrosis factor-alpha, IL-6 and IL-8 release by human monocytes and alveolar macrophages. J. Immunol. 150:2885-2891.
12. Dziarski, R., R. I. Tapping, and P. S. Tobias. 1998. Binding of bacterial peptidoglycan to CD14. J. Biol. Chem. 273:8680-8690.
13. Elass-Rochard, E., D. Legrand, V. Salmon, A. Roseanu, M. Trif, P. S. Tobias, J. Mazurier, and G. Spik. 1998. Lactoferrin inhibits the endotoxin interaction with CD14 by competition with the lipopolysaccharide-binding protein. Infect. Immun. 66:486-491.
14. Elass-Rochard, E., A. Roseanu, D. Legrand, M. Trif, V. Salmon, C. Motas, J. Montreuil, and G. Spik. 1995. Lactoferrin-lipopolysaccharide interaction: involvement of the 28-34 loop region of human lactoferrin in the high-affinity binding to Escherichia coli O55B5 lipopolysaccharide. Biochem. J. 312:839-845.
15. Fernig, D. G., P. S. Rudland and J. A. Smith. 1992. Rat mammary myoepithelial-like cells in culture possess kinetically distinct low-affinity receptors for fibroblast growth factor that modulate growth stimulatory responses. Growth Factors 7:27-39.
16. Frey, E. A., D. S. Miller, T. G. Jahr, A. Sundan, V. Bazil, T. Espevik, B. B. Finlay, and S. D. Wright. 1992. Soluble CD14 participates in the response of cells to lipopolysaccharide. J. Exp. Med. 176:1665-1671.
17. Gupta, D., T. N. Kirkland, S. Viriyakosol, and R. Dziarski. 1996. CD14 is a cell-activating receptor for bacterial peptidoglycan. J. Biol. Chem. 271:23310-23316.
18. Hailman, E., H. S. Lichenstein, M. M. Wurfel, D. S. Miller, D. A. Johnson, M. Kelley, L. A. Busse, M. M. Zukowski, and S. D. Wright. 1994. Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14. J. Exp. Med. 179:269-277.
19. Haziot, A., G. W. Rong, J. Silver, and S. M. Goyert. 1993. Recombinant soluble CD14 mediates the activation of endothelial cells by lipopolysaccharide. J. Immunol. 151:1500-1507.
20. Hess, D. C., Y. Thompson, A. Sprinkle, J. Carroll, and J. Smith. 1996. E-selectin expression on human brain microvascular endothelial cells. Neurosci. Lett. 213:37-40.
21. Jaffe, E. A., R. L. Nachman, C. G. Becker, and C. R. Minick. 1973. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J. Clin. Investig. 52:2745-2756.
22. Juan, T. S., E, Hailman, M. J. Kelley, S. D. Wright, and H. S. Lichenstein. 1995. Identification of a domain in soluble CD14 essential for lipopolysaccharide (LPS) signaling but not LPS binding. J. Biol. Chem. 270:17237-17242.
23. Juan, T. S., E. Hailman, M. J. Kelley, L. A. Busse, E. Davy, C. J. Empig, L. O. Narhi, S. D. Wright, and H. S. Lichenstein. 1995. Identification of a lipopolysaccharide binding domain in CD14 between amino acids 57 and 64. J. Biol. Chem. 270:5219-5224.
24. Lee, C. H., Y. A. Reid, J. S. Jong, and Y. H. Kang. 1995. Lipopolysaccharide-induced differential cell surface expression of intercellular adhesion molecule-1 in cultured human umbilical cord vein endothelial cells. Shock 3:96-101.
25. Lee, W. J., J. L. Farmer, M. Hilty, and Y. B. Kim. 1998. The protective effects of lactoferrin feeding against endotoxin lethal shock in germfree piglets. Infect. Immun. 66:1421-1426.
26. Legrand, D., J. Mazurier, P. Maes, E. Rochard, J. Montreuil, and G. Spik. 1991. Inhibition of the specific binding of human lactotransferrin to human peripheral-blood phytohaemagglutinin-stimulated lymphocytes by fluorescein labelling and location of the binding site. Biochem. J. 276:733-738.
27. Legrand, D., P. H. Van Berkel, V. Salmon, H. A. Van Veen, M. C. Slomianny, J. H. Nuijens, and G. Spik. 1997. The N-terminal Arg2, Arg3 and Arg4 of human lactoferrin interact with sulphated molecules but not with the receptor present on Jurkat human lymphoblastic T-cells. Biochem. J. 327:841-846.
28. Leveugle, B., J. Mazurier, D. Legrand, C. Mazurier, J. Montreuil, and G. Spik. 1993. Lactotransferrin binding to its platelet receptor inhibits platelet aggregation. Eur. J. Biochem. 213:1205-1211.
29. Machnicki, M., M. Zimecki, and T. Zagulski. 1993. Lactoferrin regulates the release of tumour necrosis factor alpha and interleukin 6 in vivo. Int. J. Exp. Pathol. 74:433-439.
30. Mann, D. M., E. Romm, and M. Migliorini. 1994. Delineation of the glycosaminoglycan-binding site in the human inflammatory response protein lactoferrin. J. Biol. Chem. 269:23661-23667.
31. Masson, P. L., J. F. Heremans, and E. Schonne. 1969. Lactoferrin, an iron-binding protein in neutrophilic leukocytes. J. Exp. Med. 130:643-658.
32. Mattsby-Baltzer, I., P. Gemski, and C. R. Alving. 1984. Heterogeneity of lipid A: comparison of lipid A types from different gram-negative bacteria. J. Bacteriol. 159:900-904.
33. Mattsby-Baltzer, I., A. Roseanu, C. Motas, J. Elverfors, I. Engberg, and L. A. Hanson. 1996. Lactoferrin or a fragment thereof inhibits the endotoxin-induced interleukin-6 response in human monocytic cells. Pediatr. Res. 40: 257-262.
34. Mayeux, P. R. 1997. Pathobiology of lipopolysaccharide. J. Toxicol. Environ. Health 51:415-435.
35. Mazurier, J., and G. Spik. 1980. Comparative study of the iron-binding properties of human transferrins. I. Complete and sequential iron saturation and desaturation of the lactotransferrin. Biochim. Biophys. Acta 629:399-408.
36. Pugin, J., C. C. Schurer-Maly, D. Leturcq, A. Moriarty, R. J. Ulevitch, and P. S. Tobias. 1993. Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc. Natl. Acad. Sci. USA 90:2744-2748.
37. Rahmoune, H., P. S. Rudland, J. T. Gallagher, and D. G. Fernig. 1998. Hepatocyte growth factor/scatter factor has distinct classes of binding site in heparan sulfate from mammary cells. Biochemistry 37:6003-6008.
38. Rahmoune, H., H. L. Chen, J. T. Gallagher, P. S. Rudland, and D. G. Fernig. 1998. Interaction of heparan sulfate from mammary cells with acidic fibroblast growth factor (FGF) and basic FGF. Regulation of the activity of basic FGF by high and low affinity binding sites in heparan sulfate. J. Biol. Chem. 273:7303-7310.
39. Spik, G., G. Strecker, B. Fournet, S. Bouquelet, J. Montreuil, L. Dorland, H. Van Halbeek, and J. F. Vliegenthart. 1982. Primary structure of the glycans from human lactotransferrin. Eur. J. Biochem. 121:413-419.
40. Stelter, F., H. Loppnow, R. Menzel, U. Grunwald, M. Bernheiden, R. S. Jack, A. J. Ulmer, and C. Schutt. 1999. Differential impact of substitution of amino acids 9-13 and 91-101 of human CD14 on soluble CD14-dependent activation of cells by lipopolysaccharide. J. Immunol. 163:6035-6044.
41. Stelter, F., M. Pfister, M. Bernheiden, R. S. Jack, P. Bufler, H. Engelmann, and C. Schutt. 1996. The myeloid differentiation antigen CD14 is N-and O-glycosylated. Contribution of N-linked glycosylation to different soluble CD14 isoforms. Eur. J. Biochem. 236:457-464.
42. Tapping, R. I., and P. S. Tobias. 1997. Cellular binding of soluble CD14 requires lipopolysaccharide (LPS) and LPS-binding protein. J. Biol. Chem. 272:23157-23164.
43. Tobias, P. S., R. I. Tapping, and J. A. Gegner. 1999. Endotoxin interactions with lipopolysaccharide-responsive cells. Clin. Infect. Dis. 28:476-481.
44. Tobias, P. S., K. Soldau, and R. J. Ulevitch. 1989. Identification of a lipid A binding site in the acute phase reactant lipopolysaccharide binding protein. J. Biol. Chem. 264:10867-10871.
45. Tobias, P. S., J. C. Mathison, and R. J. Ulevitch. 1988. A family of lipopolysaccharide binding proteins involved in responses to gram-negative sepsis. J. Biol. Chem. 263:13479-13481.
46. Tobias, P. S., K. Soldau, J. A. Gegner, D. Mintz, and R. J. Ulevitch. 1995. Lipopolysaccharide binding protein-mediated complexation of lipopolysaccharide with soluble CD14. J. Biol. Chem. 270:10482-10488.
47. Van Berkel, P. H., M. E. Geerts, H. A. Van Veen, M. Mericskay, H. A. de Boer, and J. H. Nuijens. 1997. N-terminal stretch Arg2, Arg3, Arg4 and Arg5 of human lactoferrin is essential for binding to heparin, bacterial lipopolysaccharide, human lysozyme and DNA. Biochem. J. 328:145-151.
48. Viriyakosol, S., and T. N. Kirkland. 1995. A region of human CD14 required for lipopolysaccharide binding. J. Biol. Chem. 270:361-368.
49. Wellicome, S. M., M. H. Thornhill, C. Pitzalis, D. S. Thomas, J. S. Lanchbury, G. S. Panayi, and D. O. Haskard. 1990. A monoclonal antibody that detects a novel antigen on endothelial cells that is induced by tumor necrosis factor, IL-1, or lipopolysaccharide. J. Immunol. 144:2558-2565.
50. Wright, S. D., R. A. Ramos, P. S. Tobias, R. J. Ulevitch, and J. C. Mathison. 1990. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249:1431-1433.
51. Zagulski, T., P. Lipinski, A. Zagulska, S. Broniek, and Z. Jarzabek. 1989. Lactoferrin can protect mice against a lethal dose of Escherichia coli in experimental infection in vivo. Br. J. Exp. Pathol. 70:697-704.
52. Ziegler-Heitbrock, H. W., and R. J. Ulevitch. 1993. CD14: cell surface receptor and differentiation marker. Immunol. Today 14:121-125.